Cargando…
PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy
In the present study, we analyzed Programmed Death Ligand-1 (PD-L1) expression in radical cystectomy (RC) specimens from patients with muscle-invasive urothelial carcinoma (UC), in order to assess any correlations with specific clinicopathological features and its potential prognostic value. A multi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146852/ https://www.ncbi.nlm.nih.gov/pubmed/33925149 http://dx.doi.org/10.3390/life11050404 |
_version_ | 1783697493187362816 |
---|---|
author | Nechifor-Boilă, Ioan Alin Loghin, Andrada Nechifor-Boilă, Adela Decaussin-Petrucci, Myriam Voidăzan, Septimiu Chibelean, Bogdan Călin Martha, Orsolya Borda, Angela |
author_facet | Nechifor-Boilă, Ioan Alin Loghin, Andrada Nechifor-Boilă, Adela Decaussin-Petrucci, Myriam Voidăzan, Septimiu Chibelean, Bogdan Călin Martha, Orsolya Borda, Angela |
author_sort | Nechifor-Boilă, Ioan Alin |
collection | PubMed |
description | In the present study, we analyzed Programmed Death Ligand-1 (PD-L1) expression in radical cystectomy (RC) specimens from patients with muscle-invasive urothelial carcinoma (UC), in order to assess any correlations with specific clinicopathological features and its potential prognostic value. A multi-institutional study was performed within the departments of urology and pathology at the Mureș County Hospital, Romania, and Centre Hospitalier Lyon Sud, France. Sixty-nine patients with MIBC were included, for whom tumor histology (conventional versus histological variant/differentiation), tumor extension (T), lymph node involvement (N), and distant metastases (M) were recorded. PD-L1 immunostaining was performed using the 22C3 clone and was interpreted using the combined positive score (CPS) as recommended (Dako Agilent, Santa Clara, CA, USA). Positive PD-L1 immunostaining was more prevalent among UCs with squamous differentiation compared to conventional UCs and trended towards an improved OS (p = 0.366). We found the T stage to be a risk factor for poor survival in PD-L1-positive patients (HR 2.9, p = 0.021), along with the N stage in PD-L1-negative patients (HR 1.98, p = 0.007). No other clinicopathological factor was found to be significantly associated with PD-L1 positivity. Thus, we confirm the need for PD-L1 immunostaining prior to initiating immune checkpoint inhibitor therapy for a more accurate assessment of the patients’ chances of responding to treatment. |
format | Online Article Text |
id | pubmed-8146852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81468522021-05-26 PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy Nechifor-Boilă, Ioan Alin Loghin, Andrada Nechifor-Boilă, Adela Decaussin-Petrucci, Myriam Voidăzan, Septimiu Chibelean, Bogdan Călin Martha, Orsolya Borda, Angela Life (Basel) Article In the present study, we analyzed Programmed Death Ligand-1 (PD-L1) expression in radical cystectomy (RC) specimens from patients with muscle-invasive urothelial carcinoma (UC), in order to assess any correlations with specific clinicopathological features and its potential prognostic value. A multi-institutional study was performed within the departments of urology and pathology at the Mureș County Hospital, Romania, and Centre Hospitalier Lyon Sud, France. Sixty-nine patients with MIBC were included, for whom tumor histology (conventional versus histological variant/differentiation), tumor extension (T), lymph node involvement (N), and distant metastases (M) were recorded. PD-L1 immunostaining was performed using the 22C3 clone and was interpreted using the combined positive score (CPS) as recommended (Dako Agilent, Santa Clara, CA, USA). Positive PD-L1 immunostaining was more prevalent among UCs with squamous differentiation compared to conventional UCs and trended towards an improved OS (p = 0.366). We found the T stage to be a risk factor for poor survival in PD-L1-positive patients (HR 2.9, p = 0.021), along with the N stage in PD-L1-negative patients (HR 1.98, p = 0.007). No other clinicopathological factor was found to be significantly associated with PD-L1 positivity. Thus, we confirm the need for PD-L1 immunostaining prior to initiating immune checkpoint inhibitor therapy for a more accurate assessment of the patients’ chances of responding to treatment. MDPI 2021-04-28 /pmc/articles/PMC8146852/ /pubmed/33925149 http://dx.doi.org/10.3390/life11050404 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nechifor-Boilă, Ioan Alin Loghin, Andrada Nechifor-Boilă, Adela Decaussin-Petrucci, Myriam Voidăzan, Septimiu Chibelean, Bogdan Călin Martha, Orsolya Borda, Angela PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy |
title | PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy |
title_full | PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy |
title_fullStr | PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy |
title_full_unstemmed | PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy |
title_short | PD-L1 Expression in Muscle Invasive Urothelial Carcinomas as Assessed via Immunohistochemistry: Correlations with Specific Clinical and Pathological Features, with Emphasis on Prognosis after Radical Cystectomy |
title_sort | pd-l1 expression in muscle invasive urothelial carcinomas as assessed via immunohistochemistry: correlations with specific clinical and pathological features, with emphasis on prognosis after radical cystectomy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146852/ https://www.ncbi.nlm.nih.gov/pubmed/33925149 http://dx.doi.org/10.3390/life11050404 |
work_keys_str_mv | AT nechiforboilaioanalin pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT loghinandrada pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT nechiforboilaadela pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT decaussinpetruccimyriam pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT voidazanseptimiu pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT chibeleanbogdancalin pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT marthaorsolya pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy AT bordaangela pdl1expressioninmuscleinvasiveurothelialcarcinomasasassessedviaimmunohistochemistrycorrelationswithspecificclinicalandpathologicalfeatureswithemphasisonprognosisafterradicalcystectomy |